Get started
Range Cancer Therapeutics ETFRange Cancer Therapeutics ETFRange Cancer Therapeutics ETF

Range Cancer Therapeutics ETF

No trades
See on Supercharts
Overview Analysis
Holdings
News Ideas Discussions Technicals Seasonals

Range Cancer Therapeutics ETF holdings


As of April 2, 2025
Symbol
Weight %
Shares
Shares Chg %
1M
Market value
Market value Chg %
1M
H
HCMHUTCHMED (China) Limited Sponsored ADR
1.84%
‪‪8.41 K‬‬
−11.64%
‪‪133.78 K‬‬USD
−11.69%
I
IBRXImmunityBio Inc
1.84%
‪‪43.78 K‬‬
−2.93%
‪‪133.52 K‬‬USD
+3.88%
R
RAPTRAPT Therapeutics, Inc.
1.82%
‪‪113.74 K‬‬
+35.86%
‪‪131.94 K‬‬USD
+50.09%
S
SMMTSummit Therapeutics Inc
1.78%
‪‪6.33 K‬‬
+18.50%
‪‪129.47 K‬‬USD
+26.74%
I
INBXInhibrx Biosciences, Inc.
1.77%
‪‪9.14 K‬‬
+1.20%
‪‪128.85 K‬‬USD
+5.07%
Y
YMABY-mAbs Therapeutics, Inc.
1.77%
‪‪26.76 K‬‬
+121.21%
‪‪128.46 K‬‬USD
+104.59%
T
TSVT2seventy Bio, Inc.
1.76%
‪‪25.73 K‬‬
−21.35%
‪‪127.65 K‬‬USD
+57.30%
E
EXELExelixis, Inc.
1.76%
‪‪3.44 K‬‬
−39.95%
‪‪127.45 K‬‬USD
−42.30%
S
SNDXSyndax Pharmaceuticals Inc
1.75%
‪‪9.77 K‬‬
+12.96%
‪‪126.70 K‬‬USD
−5.35%
B
BMYBristol-Myers Squibb Company
1.74%
‪‪2.12 K‬‬
−32.58%
‪‪126.53 K‬‬USD
−32.89%
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.